PubMed Articles Scraper πŸ“šπŸŽ“

Easily retrieve relevant academic articles from PubMed with this powerful scraper πŸ”. Customize results with filters like max items to extract πŸ”’ and sorting options like "e.g Best match" πŸ†. Ideal for medical research, scientific papers, and gathering references fast! 🌍

Publisher description, verbatim
Last 7 dayson this actor
Each one reaches followers by email the morning after.Follow this actor
Key figures30 readings
Price / month$18.99monthly rental
Users / 30d0→ 0 over 30 readings
Users, all time33→ 0 over 30 readings
Runs / 30d29→ 0 over 30 readings
Runs / user / moβ€”runs per monthly user
Standing
#69of 70

on PubMed, by users in the last 30 days among actors classified to this platform.

Recorded changes

No price, README, schema or grade changes in the last 30 days · followers get the next one by email.

History

30 readings since 2026-08-27
Users / 30d30 readings
08-27→ 009-25
Users, all time30 readings
08-27→ 009-25
Runs / 30d30 readings
08-27→ 009-25
Standing30 readings
08-27↑ 1209-25

Alternatives on PubMed

The actors either side of #69 of 70, ranked by users in the last 30 days. Same platform, adjacent adoption — the comparable set.

all 70 on PubMed →
Sort
#ActorGradePrice / 1kUsers /30dSuccessRatingAgeFresh
64β€”RES$50.00 /1k07 totalβ€”β€”6maging
65β€”EVT$2.25 /1k record-returned01 totalβ€”β€”53dfresh
66β€”EVT$20.00 /1k search_papers03 totalβ€”β€”5maging
67CEVT$15.00 /1k trial_row02 total100.0%5.0 (2)5maging
68β€”EVT$0.05 /1k apify-actor-start047 totalβ€”β€”12mfresh
69β€”RENT$18.99 /mo033 totalβ€”5.0 (1)18magingThis
70β€”RES$4.00 /1k04 totalβ€”β€”5mfresh

Follow this actor, compare it against its rivals, and get every overnight change in one morning report.

Publish it yourself? Claim your publisher page and its full history is yours free, forever.

Open in the app Claim this page

Numbers on this page are measured only by an independent census of the Apify Store — not self-reported. Not indexed: too little has happened to this actor for us to have anything worth saying yet.